FDA OKs label update for etravirine
FDA has approved a label update to include a 200-mg formulation of etravirine (Intelence, Tibotec
Therapeutics), a non-nucleoside reverse transcriptase inhibitor indicated for the treatment of HIV-1 in adults
resistant to an NNRTI and other antiretroviral agents. (Source: Drug Topics - Pharmacy News)
Obama administration to spend $50 million more on Alzheimer's
(Reuters) - The Obama administration said on Tuesday it will spend an additional $50 million immediately to bolster research for Alzheimer's, a fatal, brain-wasting disease that affects 5 million Americans. (Source: Reuters: Health)
